Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.38 |
| ▸ | HTR1A | P08908 | 2/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.38 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.38 |
| ▸ | GALR3 | O60755 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL10629539 | 0.98 | THRB (0.50) | TSHRTHRBALDH1A1CHRM5CHRM1 | |
| Bromide SCHEMBL17536050 | 0.98 | TSHR (0.48) | TSHRTHRBALDH1A1CHRM5CHRM1 | |
| Iodide SCHEMBL21253234 | 0.98 | TSHR (0.48) | TSHRTHRBALDH1A1CHRM5CHRM1 | |
| SCHEMBL28044392 | 0.98 | TSHR (0.48) | TSHRTHRBALDH1A1CHRM5CHRM1 | |
| SCHEMBL1262355 | 0.90 | TSHR (0.42) | TSHRTHRBALDH1A1CHRM5CHRM1 | |
| Methacrylic Acid SCHEMBL28074139 | 0.90 | THRB (0.44) | TSHRTHRBALDH1A1CHRM5CHRM1 | |
| SCHEMBL11760936 | 0.85 | TSHR (0.39) | TSHRTHRBALDH1A1GALR3POLB | |
| SCHEMBL4937680 | 0.85 | TSHR (0.39) | TSHRTHRBALDH1A1GALR3 | |
| SCHEMBL5145800 | 0.82 | THRB (0.42) | TSHRTHRBALDH1A1 | |
| SCHEMBL671829 | 0.80 | THRB (0.47) | TSHRTHRBALDH1A1CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6932984-B1 | Method of microencapsulation | TAGRA BIOTECHNOLOGIES LTD. (IL) | 2005-08-23 | — | — | US | claimed |
| US-6635277-B2 | Once-a-day controlled release treatment for cardiovascular disorders; bioavailability | WOCKHARDT LIMITED (IN) | 2003-10-21 | — | — | US | claimed |
| US-20030003149-A1 | Composition for pulsatile delivery of diltiazem and process of manufacture | WOCKHARDT LIMITED (IN) | 2003-01-02 | — | — | US | claimed |
| US-20260138230-A1 | POLISHING COMPOSITION FOR SEMICONDUCTOR PROCESS AND SUBSTRATE POLISHING METHOD USING THE SAME | SK ENPULSE CO., LTD. (KR) | 2026-05-21 | — | — | US | disclosed |
| EP-4726004-A1 | POLISHING COMPOSITION FOR SEMICONDUCTOR PROCESS AND SUBSTRATE POLISHING METHOD USING SAME | SK enpulse Co., Ltd. (KR) | 2026-04-15 | — | — | EP | disclosed |
| WO-2025014039-A1 | POLISHING COMPOSITION FOR SEMICONDUCTOR PROCESS AND SUBSTRATE POLISHING METHOD USING SAME | 에스케이엔펄스 주식회사 | 2025-01-16 | — | — | WO | disclosed |
| US-11390717-B2 | Coating composition | LG CHEM, LTD. (KR) | 2022-07-19 | — | — | US | disclosed |
| EP-3536752-B1 | COATING COMPOSITION | LG CHEMICAL LTD (KR) | 2021-12-29 | — | — | EP | disclosed |
| US-10767056-B2 | Coating composition including a salt having a silsesquioxane anion | LG CHEM, LTD. (KR) | 2020-09-08 | — | — | US | disclosed |
| EP-3536751-B1 | COATING COMPOSITION | LG CHEMICAL LTD (KR) | 2020-09-02 | — | — | EP | disclosed |
| US-20190276620-A1 | COATING COMPOSITION | LG CHEM, LTD. (KR) | 2019-09-12 | — | — | US | disclosed |
| EP-2473095-B1 | ORAL DOSAGE FORM, COMPRISING AT LEAST ONE BIOLOGICALLY ACTIVE AGENT, FORMULATION AUXILIARY SUBSTANCES AND MAGNETIZABLE PARTICLES | EVONIK ROEHM GMBH (DE) | 2014-11-12 | — | — | EP | disclosed |
| EP-2473095-A1 | ORAL DOSAGE FORM, COMPRISING AT LEAST ONE BIOLOGICALLY ACTIVE AGENT, FORMULATION AUXILIARY SUBSTANCES AND MAGNETIZABLE PARTICLES | Evonik Röhm GmbH (DE) | 2012-07-11 | — | — | EP | disclosed |
| US-20120143039-A1 | ORAL DOSAGE FORM, COMPRISING AT LEAST ONE BIOLOGICALLY ACTIVE AGENT, FORMULATION AUXILIARY SUBSTANCES AND MAGNETIZABLE PARTICLES | EVONIK ROEHM GMBH (DE) | 2012-06-07 | — | — | US | disclosed |
| WO-2011026808-A1 | ORAL DOSAGE FORM, COMPRISING AT LEAST ONE BIOLOGICALLY ACTIVE AGENT, FORMULATION AUXILIARY SUBSTANCES AND MAGNETIZABLE PARTICLES | EVONIK RÖHM GMBH (DE) | 2011-03-10 | — | — | WO | disclosed |
| WO-2010007222-A1 | METHOD FOR THE ASSISTED RECOVERY OF HYDROCARBONS USING ASSOCIATIVE POLYMERS | IFP (FR) | 2010-01-21 | — | — | WO | disclosed |
| US-6635277-B2 | Once-a-day controlled release treatment for cardiovascular disorders; bioavailability | WOCKHARDT LIMITED (IN) | 2003-10-21 | — | — | US | disclosed |
| US-20030003149-A1 | Composition for pulsatile delivery of diltiazem and process of manufacture | WOCKHARDT LIMITED (IN) | 2003-01-02 | — | — | US | disclosed |
| US-5939469-A | Coating materials for ink-jet printing | BASF AKTIENGESELLSCHAFT (DE) | 1999-08-17 | — | — | US | disclosed |
| US-4631226-A | ACRYLATE AND OXIRANYL ACRYLATE COPOLYMERS, POLYAMINES FOR SHRINKAGE RESISTANCE IN WOOL, COTTON | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1986-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138230-A1 | POLISHING COMPOSITION FOR SEMICONDUCTOR PROCESS AND SUBSTRATE POLISHING METHOD USING THE SAME | PRKG1, PRKG2, DNMT3A | TSHR 2869/4885THRB 3811/4885ALDH1A1 1645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.